NCT02264028View on ClinicalTrials.gov

Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL in 12 Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2004

Conditions
Healthy
Interventions
DRUG

[14C]-DK-AH 269 CL, solution for infusion

DRUG

[14C]-DK-AH 269 CL, drinking solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY